The Prognosis after Multidisciplinary Treatment for Patients with Postinfectious Chronic Fatigue Syndrome and Noninfectious Chronic Fatigue Syndrome

Journal of Behavioral Medicine

Volumn 25, Issue 5, 2002, Pages 487-497

  Masuda, Akinori ^a   Nakayama, Takashi ^a   Yamanaka, Takao ^b   Koga, Yasuyuki ^c   Tei, Chuwa ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF FITNESS AND SPORTS IN KANOYA   (Japan)

^c NISHIKYUSHU UNIVERSITY   (Japan)

Author keywords

Chronic fatigue syndrome; Cognitive behavioral therapy; Multidisciplinary treatment; Prognosis

Indexed keywords

ANTIDEPRESSANT AGENT; ASCORBIC ACID; CHINESE DRUG; HERBACEOUS AGENT;

ADULT; ARTICLE; BEHAVIOR THERAPY; CELL ACTIVITY; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; FEEDBACK SYSTEM; FEMALE; HUMAN; HYPERTHERMIC THERAPY; KINESIOTHERAPY; MALE; MASSAGE; MENTAL DISEASE; NATURAL KILLER CELL; NONINFECTIOUS CHRONIC FATIGUE SYNDROME; PATIENT COUNSELING; POSTINFECTIOUS CHRONIC FATIGUE SYNDROME; PROGNOSIS; TRAINING; WORK RESUMPTION; COGNITIVE THERAPY; COMPARATIVE STUDY; IMMUNOLOGY; INFECTION; METHODOLOGY; PATIENT CARE; PSYCHOSOMATICS; TREATMENT OUTCOME; VIRUS INFECTION;

ADULT; COGNITIVE THERAPY; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; INFECTION; KILLER CELLS, NATURAL; MALE; PATIENT CARE TEAM; PROGNOSIS; PSYCHOSOMATIC MEDICINE; TREATMENT OUTCOME; VIRUS DISEASES;

EID: 0036783013     PISSN: 01607715     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020475108745     Document Type: Article

References (23)

1. Behan, P. O., Behan, W. M. H., and Horrobin, D. F. (1990). The use of essential fatty acids in chronic fatigue syndrome. Acta. Neurol. Scand. 82: 209-216.
2. Butler, S., Chalder, T., Ron, M., and Wessely, S. (1991). Cognitive behaviour therapy in chronic fatigue syndrome. J. Neurol. Neurosurg. Psychiatry 54: 153-158.
3. Cox, I. M., Campbell, M. J., and Dowson, D. (1991). Red blood cell magnesium and chronic fatigue syndrome. Lancet 337: 757-760.
4. David, A. S. (1991). Postviral fatigue syndrome and psychiatry. Brit. Med. Bull. 47: 966-988.
5. David, R. M. (1993). Pharmacological approaches to the therapy of chronic fatigue syndrome. Ciba Found. Sympo. 173: 280-287.
6. Deale, A., Chalder, T., Marks, I., and Wessely, S. (1997). A randomised controlled trial of cognitive behavior versus relaxation therapy for chronic fatigue syndrome, Am. J. Psychiatry 154:408-414.
7. Fulcher, K. Y., and White, P. D. (1997). Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome. BMJ 314: 1647-1652.
8. Ganty, N. M., and Holmes, G. P. (1989). Treatment of patients with chronic fatigue syndrome. Drugs 38: 855-862.
9. Goldenberg, D. L., Felson, D. T., and Dinerman, H. (1986). A randomized controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum. 29:1371-1377.
10. Hawton, K. E., Salkovskis, P. M., Kirk, J., and Clark, D. M. (1989). Cognitive Behaviour Therapy for Psychiatric Problems: A Practical Guide, Oxford Medical Publications, Oxford University Press, London.
11. Hickie, I., Lloyd, A., Wakefield, D., and Parker, G. (1987). The psychiatric straus of patients with chronic fatigue syndrome. Br. J. Psychiatry 156:534-540.
12. Irwin, M., and Gillin, J. C. (1987). Impaired natural killer cell activity among depressive patients. Psychiatry Res. 20: 181-182.
13. Levine, P. H. (1997). Epidemiologic advances in chronic fatigue syndrome. J. Psychiatr. Res. 31: 7-18.
14. Masuda, A., Nozoe, S., Naruo, T., Soejima, Y., Nagai, N., Koga, Y., and Tanaka, H. (1995). Natural killer cell activity in relation to psychobehavioral responses, stress coping behavior, and fatigue in healthy adult men. Jpn. J. Psychosom. Med. 35: 383-390.
15. O'Leary, A., Shoor, S., Lorig, K., and Holman, H. R. (1988). A cognitive-behavioral treatment for rheumatoid arthritis. Health Psychol. 7: 527-544.
16. Salit, I. E. (1997). Precipitating factors for the chronic fatigue syndrome. J. Psychiatr. Res. 31: 59-65.
17. Schluenderberg, A., Straus, S. E., Peterson, P., Blumenthal, S., Komaroff, A. L., Spring, S. B., Landy, A., and Buchwald, D. (1992). Chronic fatigue syndrome research-Definition and medical outcome assessment. Ann. Intern. Med. 117: 325-331.
18. Sharpe, M. C., Poveler, R., and Mayou, R. (1992). Psychological treatment of functional somatic symptoms: A practical guide. J. Psychosom. Res. 36: 515-527.
19. Straus, S. E., Dale, J. K., Tobi, M., Lawley, T., Preble, O., Blaese, R. M., Hallahan, C., and Henle, W. (1988). Acyclovir treatment of the chronic fatigue syndrome: Lack of efficacy in a placebo-controlled trial. N. Engl. J. Med. 319:1692-1698.
20. Vercoulen, J., Swanink, C., Fennis, J., Galama, J., Meer, J., and Bleijenberg, G. (1996a). Prognosis in chronic fatigue syndrome: A prospective study on the natural course. J. Nuerol. Neurosurg. Psychiatry 60: 489-494.
21. Vercoulen, J., Swanink, C., Zitman, F., Vreden, S., Hoofs, M., Fennis, J., Galama, J., Meer, J., and Bleijenberg, G. (1996b). Rondomized, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 347: 858-861.
22. Wearden, A., Morriss, R., Mullis, R., Strickland, P. L., Pearson, D. J., Appleby, L., Campbell, I. T., and Morris, J. A. (1998). Rondomized, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome. Br. J. Psychiatry 172: 485-490.
23. Wilson, A., Hikie, I., Lloyd, A., and Wakefield, D. (1994). The treatment of chronic fatigue syndrome: Science and Speculation. Am. J. Med. 96: 544-550.